Ignite Creation Date:
2024-05-06 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 12:47 PM
Study NCT ID:
NCT03555877
Status:
COMPLETED
Last Update Posted:
2023-07-07
First Post:
2018-02-16
Brief Title:
Anti-hormonal Therapie With Ribociclib in HR-positive HER2- Negative Metastatic Breast Cancer
Sponsor:
German Breast Group
Organization:
German Breast Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-03-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-21
Completion Date Type:
ACTUAL
First Submit Date:
2018-02-16
First Submit QC Date:
June 1 2018
Study First Post Date:
2018-06-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-06
Last Update Post Date:
2023-07-07
Last Update Post Date Type:
ACTUAL